Vivani Medical, Inc. (VANI)
USD 0.99
(-1.98%)
USD 0.99
(-1.98%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -26.6 Million USD | 4.07% |
| 2022 | -19.16 Million USD | -103.66% |
| 2021 | -12.97 Million USD | -53.21% |
| 2020 | -8.88 Million USD | 70.55% |
| 2019 | -33.17 Million USD | 12.23% |
| 2018 | -34.65 Million USD | -21.73% |
| 2017 | -28.05 Million USD | 13.81% |
| 2016 | -32.74 Million USD | -66.28% |
| 2015 | -19.68 Million USD | 29.32% |
| 2014 | -27.88 Million USD | -58.1% |
| 2013 | -17.63 Million USD | -12.44% |
| 2012 | -15.68 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -6.12 Million USD | -0.15% |
| 2024 Q2 | -5.58 Million USD | 8.93% |
| 2023 Q2 | -6.92 Million USD | -4.88% |
| 2023 Q3 | -7.07 Million USD | -2.17% |
| 2023 Q1 | -6.6 Million USD | 14.05% |
| 2023 FY | - USD | 4.07% |
| 2023 Q4 | -6.11 Million USD | 13.49% |
| 2022 Q3 | -5.44 Million USD | -33.2% |
| 2022 Q1 | -3.82 Million USD | -10.36% |
| 2022 FY | - USD | -103.66% |
| 2022 Q4 | -7.68 Million USD | -41.07% |
| 2022 Q2 | -4.08 Million USD | -6.88% |
| 2021 Q3 | -3.48 Million USD | -53.19% |
| 2021 Q4 | -3.46 Million USD | 0.57% |
| 2021 Q1 | -2.88 Million USD | -126.43% |
| 2021 FY | - USD | -53.21% |
| 2021 Q2 | -2.27 Million USD | 21.2% |
| 2020 Q1 | -8.78 Million USD | -13.09% |
| 2020 Q4 | -1.27 Million USD | 19.35% |
| 2020 Q3 | -1.58 Million USD | 48.67% |
| 2020 Q2 | -3.08 Million USD | 64.92% |
| 2020 FY | - USD | 70.55% |
| 2019 Q1 | -9.6 Million USD | -9.7% |
| 2019 FY | - USD | 12.23% |
| 2019 Q4 | -7.76 Million USD | -3.7% |
| 2019 Q3 | -7.48 Million USD | 10.26% |
| 2019 Q2 | -8.34 Million USD | 13.1% |
| 2018 Q3 | -8.41 Million USD | -7.2% |
| 2018 FY | - USD | -21.73% |
| 2018 Q1 | -9.64 Million USD | -32.14% |
| 2018 Q2 | -7.85 Million USD | 18.59% |
| 2018 Q4 | -8.75 Million USD | -4.0% |
| 2017 FY | - USD | 13.81% |
| 2017 Q1 | -7.43 Million USD | 27.46% |
| 2017 Q2 | -6.72 Million USD | 9.52% |
| 2017 Q3 | -6.56 Million USD | 2.38% |
| 2017 Q4 | -7.29 Million USD | -11.12% |
| 2016 Q1 | -5.71 Million USD | -6.51% |
| 2016 FY | - USD | -66.28% |
| 2016 Q4 | -10.24 Million USD | -22.29% |
| 2016 Q3 | -8.38 Million USD | 0.23% |
| 2016 Q2 | -8.4 Million USD | -46.93% |
| 2015 Q1 | -4.87 Million USD | 60.85% |
| 2015 FY | - USD | 29.32% |
| 2015 Q2 | -4.84 Million USD | 0.58% |
| 2015 Q4 | -5.36 Million USD | -16.88% |
| 2015 Q3 | -4.59 Million USD | 5.23% |
| 2014 Q4 | -12.44 Million USD | -123.04% |
| 2014 Q2 | -5.48 Million USD | -25.28% |
| 2014 Q1 | -4.37 Million USD | -2.93% |
| 2014 FY | - USD | -58.1% |
| 2014 Q3 | -5.58 Million USD | -1.82% |
| 2013 Q2 | -4.02 Million USD | 17.24% |
| 2013 FY | - USD | -12.44% |
| 2013 Q1 | -4.86 Million USD | 0.0% |
| 2013 Q4 | -4.25 Million USD | 5.55% |
| 2013 Q3 | -4.5 Million USD | -11.85% |
| 2012 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -97.286% |
| Cerus Corporation | -26.53 Million USD | -0.271% |
| OrthoPediatrics Corp. | -8.38 Million USD | -217.48% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -153.543% |
| Talis Biomedical Corporation | -66.04 Million USD | 59.712% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -59.568% |
| Inogen, Inc. | -45.67 Million USD | 41.75% |
| Spectral AI, Inc. | -12.26 Million USD | -116.996% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 44.21% |
| CVRx, Inc. | -38.73 Million USD | 31.301% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -654.195% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -119.774% |
| Orthofix Medical Inc. | -86.98 Million USD | 69.411% |
| Venus Concept Inc. | -26.11 Million USD | -1.896% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 46.539% |
| Bioventus Inc. | -23.07 Million USD | -15.336% |
| BrainsWay Ltd. | -2.31 Million USD | -1051.363% |
| Envoy Medical, Inc. | -18.23 Million USD | -45.893% |
| electroCore, Inc. | -17.76 Million USD | -49.82% |
| IceCure Medical Ltd | -15.25 Million USD | -74.444% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 46.518% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -57.858% |
| MaxCyte, Inc. | -44.12 Million USD | 39.703% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -126.336% |
| Nexalin Technology, Inc. | -5.69 Million USD | -367.46% |
| PAVmed Inc | -75.74 Million USD | 64.87% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 50.504% |
| RxSight, Inc. | -41.03 Million USD | 35.161% |
| Sight Sciences, Inc. | -49.41 Million USD | 46.154% |
| SI-BONE, Inc. | -34.44 Million USD | 22.754% |
| TELA Bio, Inc. | -40.63 Million USD | 34.516% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 54.359% |
| Treace Medical Concepts, Inc. | -39 Million USD | 31.788% |
| LivaNova PLC | 39.01 Million USD | 168.198% |
| 908 Devices Inc. | -34.02 Million USD | 21.799% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 75.94% |
| Nemaura Medical Inc. | -7.28 Million USD | -265.141% |
| NeuroPace, Inc. | -22.83 Million USD | -16.528% |
| LENSAR, Inc. | -8.71 Million USD | -205.348% |
| Apyx Medical Corporation | -18.11 Million USD | -46.908% |
| Cutera, Inc. | -136.56 Million USD | 80.516% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -687.219% |
| BioSig Technologies, Inc. | -28.15 Million USD | 5.481% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 1157.552% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | -26.771% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 106.937% |
| Axonics, Inc. | 7.77 Million USD | 442.225% |
| Outset Medical, Inc. | -153.78 Million USD | 82.698% |
| IRIDEX Corporation | -7.44 Million USD | -257.25% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 72.875% |
| IRadimed Corporation | 20.8 Million USD | 227.919% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -230.042% |
| INVO Bioscience, Inc. | -6.88 Million USD | -286.743% |
| Telesis Bio, Inc. | -40.49 Million USD | 34.29% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 172.547% |
| Varex Imaging Corporation | 67.2 Million USD | 139.595% |
| Quipt Home Medical Corp. | 44.07 Million USD | 160.375% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -144.784% |
| Pulmonx Corporation | -55.09 Million USD | 51.703% |
| Dynatronics Corporation | -976 Thousand USD | -2626.207% |
| Modular Medical, Inc. | -17.1 Million USD | -55.575% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -83.693% |
| Semler Scientific, Inc. | 23.58 Million USD | 212.798% |
| InMode Ltd. | 196.28 Million USD | 113.556% |
| Bruker Corporation | 599 Million USD | 104.442% |
| Cytosorbents Corporation | -28.81 Million USD | 7.646% |
| DexCom, Inc. | 916.7 Million USD | 102.903% |
| Align Technology, Inc. | 799.03 Million USD | 103.33% |
| Viveve Medical, Inc. | -20.61 Million USD | -29.059% |
| ZimVie Inc. | 91.07 Million USD | 129.216% |
| Movano Inc. | -29.12 Million USD | 8.642% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -503.63% |
| Nexalin Technology, Inc. | -5.69 Million USD | -367.46% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -654.195% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 86.331% |
| Profound Medical Corp. | -27.12 Million USD | 1.9% |
| Insulet Corporation | 323.6 Million USD | 108.222% |
| enVVeno Medical Corporation | -25.01 Million USD | -6.355% |
| Surmodics, Inc. | 1.18 Million USD | 2339.731% |
| iCAD, Inc. | -6.56 Million USD | -305.301% |
| Nuwellis, Inc. | -16.35 Million USD | -62.68% |
| Biotricity, Inc. | -8.82 Million USD | -201.395% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 72.53% |
| Aethlon Medical, Inc. | -11.84 Million USD | -124.557% |
| InspireMD, Inc. | -20.91 Million USD | -27.244% |
| PAVmed Inc. | -75.74 Million USD | 64.87% |
| BIOLASE, Inc. | -15.13 Million USD | -75.758% |
| Beyond Air, Inc. | -59.03 Million USD | 54.925% |
| FONAR Corporation | 28.25 Million USD | 194.182% |
| AxoGen, Inc. | -13.32 Million USD | -99.64% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 208.423% |
| Inari Medical, Inc. | 7.11 Million USD | 474.076% |
| UFP Technologies, Inc. | 72.74 Million USD | 136.578% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -685.874% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -332.229% |
| Tenon Medical, Inc. | -15.52 Million USD | -71.355% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -74.296% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 35.847% |
| AdaptHealth Corp. | -171.09 Million USD | 84.448% |
| Sintx Technologies, Inc. | -6.6 Million USD | -303.152% |
| NanoVibronix, Inc. | -3.43 Million USD | -674.614% |
| Quanterix Corporation | -38.08 Million USD | 30.141% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -144.784% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 88793.333% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 90.404% |
| TransMedics Group, Inc. | -7.6 Million USD | -249.967% |
| ReWalk Robotics Ltd. | -21.76 Million USD | -22.251% |
| NeuroMetrix, Inc. | -7.09 Million USD | -274.982% |
| Hyperfine, Inc. | -47.06 Million USD | 43.461% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 54.366% |
| Biomerica, Inc. | -5.99 Million USD | -343.985% |
| Bone Biologics Corporation | 479.57 Thousand USD | 5648.281% |
| AVITA Medical, Inc. | -39.56 Million USD | 32.753% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -190.071% |
| Silk Road Medical, Inc | -45.08 Million USD | 40.976% |